Register
Thursday, February 23, 2012
 
You are here   Products    High Cost & Pbre Drugs
PbRe drug requests

To support the guidelines developed by National Institute for Clinical Excellence (NICE) and local commissioning criteria, Blueteq has included a library of online forms in the module to enable the rapid completion of requests by clinicians at the Trust, typically in a “tick box” and text based format. Once the request is authorised, in line with the Trust’s procedures, e.g. reviewed and submitted by the Pharmacy department, the request is then submitted on-line to the PCT complete with the guidance form. The Blueteq High Cost Drug module also caters for the submission of IFRs again via an online form and follows a similar procedure to the “tick box” approach.

These tick box forms can be easily updated by the user in line with any changes to local criteria or NICE guidance approach. This approach also cuts down on data entry time, improves the quality of information and provides greater visibility to the providers on the status of any request as well as evidence that NICE guidelines are being adhered to.

Tracking the status of requests


The High Cost Drug module enables the user to assign a status to each request and to therefore track the request through the process. The statuses required are user defined to support the process within the Trust. Reports can be produced on demand for requests awaiting further action or subsequent review.

 

Review Process
The system holds the review dates to provide an automated process to follow up patients' treatments to ensure the efficacy of continued treatment and that it is in line with NICE guidance and locally commissioned criteria.

Reporting
In a similar way a range of reports can be provided to facilitate board reporting and from experience to date the production of these vital reports now takes a matter of minutes rather than hours. These reports will be tailored to your individual requirements.

Invoice matching and challenging
A key part of this process is to be able to reconcile invoices to the patients. Without this system it is time consuming and often difficult to match the invoice to the patient, treatment and request. This is further compounded by the need to confirm whether the request is approved, the patient is registered with a practice in the PCT and whether any follow up is required.
 
The Blueteq High Cost Drug module provides the facility to import the patient schedules, supporting the invoice. The import function is user defined and is capable of supporting and managing many different formats; the minimum data required is the NHS/Hospital number, the drug and the cost.
The system allows for the manual entry of invoices, typically users will use the import routine for those invoices covering more than 3 or 4 patients.
 
Experience to date has shown that the invoice matching process is typically now a matter of minutes and saves days of staff time per month and is much more accurate. 
 
The Blueteq system is able to immediately review the invoices and determine if
  • The patient exists on the system
  • The drug exists on the system
  • Approval was given for the treatment 
  • The patient is registered with a GP practice in the PCT 
  • Any follow up for the request is outstanding
  If these criteria are not met then the PCT is able to raise a challenge against the invoice in a timely manner.

Summary
Experience from users to date confirms that the Blueteq High Cost Drug module can provide the following benefits:
  • Online submission by the trusts cuts down on inputting mistakes and missing data.
  • The Patient History displays all information and documentation in one place in a paperless medium.
  • No filing required and all vital data is immediately available to hand.
  • The automatic matching of invoices to requests is executed in minutes, saves up to a day in staff time for each invoice and is much more accurate.
  • Challenge reports easily produced for discussion with the Trusts
  • An automated process to enable patients to be followed up in a timely manner.
  • Use of PbRe drugs is in line with NICE / locally commissioned criteria.
  • Production of vital reports takes minutes instead of hours to produce.
  • Improved relationships with Providers, who have visibility of their requests